Senior Program Lead - Early-Stage Rare Disease

Alnylam Pharmaceuticals, Inc.

Cambridge (MA)

Hybrid

USD 247,000 - 334,000

Full time

14 days+

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

Alnylam Pharmaceuticals in Cambridge, MA seeks a Senior/Executive Director, Development Program Lead to shape and drive two early-stage rare disease programs in hepatobiliary space. You will build integrated development strategies and lead execution through critical milestones, guiding cross-functional teams and making investment decisions based on emerging data.

The role requires a leader who thrives in ambiguity, demonstrates strong strategic judgment, and communicates effectively with senior

Qualifications

  • Advanced degree in medicine, science, pharmacy, or related discipline.
  • 10+ years of progressively responsible experience in biotechnology or pharmaceutical drug development, including leading cross‑functional teams.
  • Rare disease drug development experience preferred.
  • Experience in early-stage development, including first‑in‑human studies and Phase 1.
  • Broad understanding of drug development and interdependencies across clinical, regulatory, safety, nonclinical, CMC, and program management.
  • Ability to lead through influence, align stakeholders, and drive decisions without formal authority.

Responsibilities

  • Lead integrated, cross-functional strategies for early-stage rare disease programs.
  • Establish program vision, milestones, and alignment across scientific, regulatory, and business considerations.
  • Develop fit-for-purpose program plans reflecting asset stage, evidence base, and investment level.
  • Define proof-of-concept strategies, decision criteria, and data requirements for evaluation and investment decisions.
  • Integrate scientific evidence, clinical data, regulatory considerations, patient needs, and external landscape into strategy.
  • Translate complex information into clear recommendations and executable plans.
  • Anticipate risks and interdependencies; establish mitigation plans and escalate issues as needed.
  • Partner with functional leaders to align resources with milestones and deliverables.
  • Foster an inclusive, high-performing team with transparent communication and timely decisions.
  • Prepare and present strategy, status, risks, and scenarios to governance and senior leadership.

Skills

Cross-functional leadership
Strategic thinking
Influence without authority
Data-driven decision making
Executive presence

Education

MD/PhD/PharmD or equivalent

Job description

Alnylam Pharmaceuticals in Cambridge, MA seeks a Senior/Executive Director, Development Program Lead to shape and drive two early-stage rare disease programs in hepatobiliary space. You will build integrated development strategies and lead execution through critical milestones, guiding cross-functional teams and making investment decisions based on emerging data.

The role requires a leader who thrives in ambiguity, demonstrates strong strategic judgment, and communicates effectively with senior

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Senior Development Program Lead, Rare Disease
Senior Development Program Lead, Rare Disease

Alnylam Pharmaceuticals, Inc. • United States

Hybrid
USD 210,000 - 310,000
Program Lead, Development - Rare Disease
Program Lead, Development - Rare Disease

Alnylam Pharmaceuticals, Inc. • United States

Hybrid
USD 210,000 - 310,000
Program Lead, Development - Rare Disease
Program Lead, Development - Rare Disease

Alnylam Pharmaceuticals, Inc. • Cambridge (MA)

Hybrid
USD 247,000 - 334,000
Senior Director, Nonclinical Toxicology & Strategy
Senior Director, Nonclinical Toxicology & Strategy

Alnylam Pharmaceuticals, Inc. • Cambridge (MA)

Hybrid
USD 223,000 - 314,000
Director, Patient Advocacy & Engagement — Rare Diseases
Director, Patient Advocacy & Engagement — Rare Diseases

Civic Science Media • Boston (MA)

Hybrid
USD 120,000 - 180,000
Senior Director, Pathology - Translational Clinical Leader
Senior Director, Pathology - Translational Clinical Leader

Alnylam Pharmaceuticals, Inc. • Cambridge (MA)

On-site
USD 226,000 - 306,000
Director, Clinical Research- Benign Hematology
Director, Clinical Research- Benign Hematology

Alnylam Pharmaceuticals, Inc. • Cambridge (MA), Philadelphia

On-site
USD 260,000 - 380,000
Clinical Development Director, RNAi Therapeutics
Clinical Development Director, RNAi Therapeutics

Alnylam Pharmaceuticals, Inc. • Cambridge (MA)

Hybrid
USD 255,000 - 345,000
Comprehensive healthcare benefits
Generous paid time off
401(k) with company match
+2
Strategic Global Medical Lead, CNS Early Assets
Strategic Global Medical Lead, CNS Early Assets

Alnylam Pharmaceuticals, Inc. • Cambridge (MA)

On-site
USD 239,000 - 323,000
Medical, dental, and vision coverage
401(k) with generous company match
Paid time off
+1
Director of Clinical Research - RNAi Therapeutics Leader
Director of Clinical Research - RNAi Therapeutics Leader

Alnylam Pharmaceuticals, Inc. • Cambridge (MA), Philadelphia

On-site
USD 260,000 - 380,000